Braathen LR - Search Results

1

Interleukin-2 primes eosinophil degranulation in hypereosinophilia and Wells' syndrome.

Simon HU, Plötz S, Simon D, Seitzer U, Braathen LR, Menz G, Straumann A, Dummer R, Levi-Schaffer F. Simon HU, et al. Among authors: braathen lr. Eur J Immunol. 2003 Apr;33(4):834-9. doi: 10.1002/eji.200323727. Eur J Immunol. 2003. PMID: 12672048 Free article.

2

Anti-interleukin-5 antibody therapy in eosinophilic diseases.

Simon D, Braathen LR, Simon HU. Simon D, et al. Among authors: braathen lr. Pathobiology. 2005;72(6):287-92. doi: 10.1159/000091326. Pathobiology. 2005. PMID: 16582580 Review.

3

The interleukin-13 production by peripheral blood T cells from atopic dermatitis patients does not require CD2 costimulation.

Simon D, Von Gunten S, Borelli S, Braathen LR, Simon HU. Simon D, et al. Among authors: braathen lr. Int Arch Allergy Immunol. 2003 Oct;132(2):148-55. doi: 10.1159/000073716. Int Arch Allergy Immunol. 2003. PMID: 14600427

4

Reduced dermal infiltration of cytokine-expressing inflammatory cells in atopic dermatitis after short-term topical tacrolimus treatment.

Simon D, Vassina E, Yousefi S, Kozlowski E, Braathen LR, Simon HU. Simon D, et al. Among authors: braathen lr. J Allergy Clin Immunol. 2004 Oct;114(4):887-95. doi: 10.1016/j.jaci.2004.05.066. J Allergy Clin Immunol. 2004. PMID: 15480330

5

Increased expression and a potential anti-inflammatory role of TRAIL in atopic dermatitis.

Vassina E, Leverkus M, Yousefi S, Braathen LR, Simon HU, Simon D. Vassina E, et al. Among authors: braathen lr. J Invest Dermatol. 2005 Oct;125(4):746-52. doi: 10.1111/j.0022-202X.2005.23878.x. J Invest Dermatol. 2005. PMID: 16185275 Free article.

6

Epidermal caspase-3 cleavage associated with interferon-gamma-expressing lymphocytes in acute atopic dermatitis lesions.

Simon D, Lindberg RL, Kozlowski E, Braathen LR, Simon HU. Simon D, et al. Among authors: braathen lr. Exp Dermatol. 2006 Jun;15(6):441-6. doi: 10.1111/j.0906-6705.2006.00428.x. Exp Dermatol. 2006. PMID: 16689860

7

Eosinophils and atopic dermatitis.

Simon D, Braathen LR, Simon HU. Simon D, et al. Among authors: braathen lr. Allergy. 2004 Jun;59(6):561-70. doi: 10.1111/j.1398-9995.2004.00476.x. Allergy. 2004. PMID: 15147438 Review.

8

[Anti-interleukin-5 therapy for eosinophilic diseases].

Simon D, Braathen LR, Simon HU. Simon D, et al. Among authors: braathen lr. Hautarzt. 2007 Feb;58(2):122, 124-7. doi: 10.1007/s00105-006-1273-x. Hautarzt. 2007. PMID: 17221241 Free article. Review. German.

9

Increased lipopolysaccharide-induced tumour necrosis factor-alpha, interferon-gamma and interleukin-10 production in atopic dermatitis.

Simon D, Braathen LR, Simon HU. Simon D, et al. Among authors: braathen lr. Br J Dermatol. 2007 Sep;157(3):583-6. doi: 10.1111/j.1365-2133.2007.08050.x. Epub 2007 Jun 26. Br J Dermatol. 2007. PMID: 17596153

10

Peripheral blood mononuclear cells from IgE- and non-IgE-associated allergic atopic eczema/dermatitis syndrome (AEDS) demonstrate increased capacity of generating interleukin-13 but differ in their potential of synthesizing interferon-gamma.

Simon D, Borelli S, Braathen LR, Simon HU. Simon D, et al. Among authors: braathen lr. Allergy. 2002 May;57(5):431-5. doi: 10.1034/j.1398-9995.2002.13506.x. Allergy. 2002. PMID: 11972483

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

222 results

Search Page

Filters